David A. Montecalvo
Net Worth
Last updated:
What is David A. Montecalvo net worth?
The estimated net worth of Mr. David A. Montecalvo is at least $6,758,197 as of 29 Jul 2020. He owns shares worth $1,558,197 as insider and has received compensation worth at least $5,200,000 in West Pharmaceutical Services, Inc..
What is the salary of David A. Montecalvo?
Mr. David A. Montecalvo salary is $1,040,000 per year as Senior Vice President and Chief Operations & Supply Chain Officer in West Pharmaceutical Services, Inc..
How old is David A. Montecalvo?
Mr. David A. Montecalvo is 60 years old, born in 1965.
What stocks does David A. Montecalvo currently own?
As insider, Mr. David A. Montecalvo owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| West Pharmaceutical Services, Inc. (WST) | Senior Vice President and Chief Operations & Supply Chain Officer | 6,309 | $246.98 | $1,558,197 |
What does West Pharmaceutical Services, Inc. do?
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
David A. Montecalvo insider trading
West Pharmaceutical Services, Inc.
Mr. David A. Montecalvo has made 3 insider trades in 2020, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 14,508 units of WST stock on 28 Jul 2020. As of 29 Jul 2020 he still owns at least 6,309 units of WST stock.
West Pharmaceutical Services key executives
West Pharmaceutical Services, Inc. executives and other stock owners filed with the SEC:
- Mr. Bernard J. Birkett (56) Senior Vice President & Chief Financial Officer
- Mr. David A. Montecalvo (60) Senior Vice President and Chief Operations & Supply Chain Officer
- Mr. Eric M. Green (55) Pres, Chief Executive Officer & Director
- Mr. Silji Abraham (53) Senior Vice President & Chief Technology Officer